Press Releases AstraZeneca PLC Nasdaq

Equities

AZN

US0463531089

Market Closed - Nasdaq Other stock markets 21:00:00 21/05/2024 BST			Pre-market 13:18:25
79.18 ^USD	+2.68%		78.25	-1.17%

01:42pm	Stifel Raises AstraZeneca PT, Maintains Buy Rating	MT
11:36am	ASTRAZENECA : Oddo BHF raises its target slightly	CF

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024	12:05pm	BU
Astrazeneca looks to double revenue in 'new era of growth'	06:21am	AQ
INSIDE XP POWER REJECTS BID ...	06:21am	AQ
AstraZeneca : Oncology presentation	05-21	PU
AstraZeneca : Rare Disease presentation	05-21	PU
AstraZeneca : BioPharmaceuticals presentation	05-21	PU
AstraZeneca : Investor Day Agenda	05-21	PU
AstraZeneca : Investor Day Biographies	05-21	PU
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030	05-21	BU
Astrazeneca set to build cancer drug plant in Singapore	05-21	AQ
AstraZeneca announces $1.5b ADC manufacturing facility	05-20	AQ
Astrazeneca - New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease	05-20	AQ
AstraZeneca : plans $1.5 billion manufacturing facility for antibody drug conjugates (ADCs) in Singapore - Form 6-K	05-20	PU
New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease	05-19	BU
AlzeCure Pharma AB - Eli Lilly's and AstraZeneca's former head of research Dr. Jan Lundberg elected as a new board member	05-16	AQ
AstraZeneca : SUPERNOVA Phase III trial of sipavibart long-acting antibody met primary endpoints in preventing COVID-19 in immunocompromised patient population - Form 6-K	05-16	PU
Insights into AstraZeneca's MANDARA Phase III data	05-16	AQ
Notice to the Annual General Meeting of Cline Scientific AB	05-16	AQ
AstraZeneca : Transaction by Person Discharging Managerial Responsibilities - Form 6-K	05-15	PU
Eli Lilly’s and AstraZeneca’s former head of research Dr. Jan Lundberg elected as a new board member	05-15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 05:02 pm